Monkeypox: generalities, transmission method and therapeutic approaches

Authors

DOI:

https://doi.org/10.33448/rsd-v11i17.38463

Keywords:

Monkeypox; Vaccines; Antivirals.

Abstract

Clinical and epidemiological studies suggest that human-to-human transmission of monkeypox may occur through direct or indirect contact, through secretions through the respiratory tract or through skin lesions, and through contaminated objects. Therefore, this literature review exposes generalities, forms of transmission and therapeutic approaches related to Monkeypox. A survey was carried out on government websites, scientific articles and journalistic websites about ways of prevention and vaccines against the monkeypox virus. It is known that this zoonosis belongs to the Poxviridae family and spreads with greater intensity in underdeveloped countries, due to the unsanitary conditions of these places. Studies indicate that vaccines produced for smallpox are efficient against Monkeypox virus, especially the third generation ones. The vaccine that obtained a better result in the research was the MVA-BN, since it does not leave lesions in the place where it was applied and does not present a threat to a possible transmission, it was also developed for immunosuppressed individuals, facilitating the mass vaccination of the vaccine. population. Some drugs have also been shown to be effective against Monkeypox, namely: Brincidofovir, Cidofovir and Tecovirimat, with Tecovirimat in evidence for its efficiency and moderate side effects.

References

Butantan Institute. (2022). Varíola dos macacos: sintomas, transmissão, origem e número de casos são atualizados pela OMS. https://butantan.gov.br/noticias/variola-dos-macacos-sintomas-transmissao-origem-e-numero-de-casos-sao-atualizados-pela-oms

Centers for Disease Control and Prevention. (2022). Monkeypox https://www.cdc.gov/poxvirus/monkeypox/clinicians/treatment.html

CNN Brasil. (2022). Como funciona o antiviral tecovirimat contra monkeypox, aprovado pela Anvisa https://www.cnnbrasil.com.br/saude/como-funciona-o-antiviral-tecovirimat-contra-monkeypox-aprovado-pela-anvisa/

Di Giulio, D. B., & Eckburg, P. B. (2004). Human monkeypox: an emerging zoonosis, 10.1016/s1473-3099(03)00856-9

European medicines Agency. (2022). Tecovirimat SIGA (tecovirimat) https://www.ema.europa.eu/en/documents/overview/tecovirimat-siga-epar-medicine-overview_pt.pdf;

G. Sambo, L. (2007). http://files.bvs.br/upload/S/1555-8746/2007/vn4/a135-154-2.pdf

Hospital Proncor. (2022). What is Monkeypox? Know the symptoms and why it affects humans https://www.hospitalproncor.com.br/amp/variola

Hospital Sírio-Libanês. (2019). Information about the drug Cidofovir https://guiafarmaceutico.hsl.org.br/cidofovir

INDICE.eu. (2022). Brincidofovir https://www.indice.eu/pt/medicamentos/DCI/brincidofovir/informacao-geral#:~:text=Brincidofovir%20%C3%A9%20indicado%20para%20o,Unidos%20em%20junho%20de%202021)

Manual MSD (2022). Antiviral Medicines https://www.msdmanuals.com/pt-pt/casa/multimedia/video/medicamentos-antivirais).

Mckeever, A. (2022). How effective is the common smallpox vaccine against monkeypox? https://www.nationalgeographicbrasil.com/ciencia/2022/08/quao-eficiente-e-a-vacina-da-variola-comum-contra-a-variola-dos-macacos

Ministry of Health. (2022). Entenda a origem da varíola dos macacos; transmissão atual ocorre somente entre humanos https://www.gov.br/saude/pt-br/assuntos/noticias/2022/agosto/entenda-a-origem-da-variola-dos-macacos-transmissao-atual-ocorre-somente-entre-humanos

Nalca, A., & Zumbrun, E. E. (2010). ACAM2000™: ACAM2000™: The new smallpox vaccine for United States Strategic National Stockpile, https://doi.org/10.2147/DDDT.S3687

National Commission for the Incorporation of Technologies in the Unified Health System. (2022). Tecovirimat for the treatment of monkeypox https://www.gov.br/conitec/pt-br/midias/radar/2022/20220909_alerta_mht_tecoviramat_monkey.pdf

Peduzzi, P. (2022). Entenda o que é a varíola dos macacos. https://agenciabrasil.ebc.com.br/saude/noticia/2022-05/entenda-o-que-e-variola-dos-macacos

Pharmacy diary. (2022). Tecovirimat – treat. ment for Monkeypoxhttps://www.diariofarma.com.br/tecovirimat-tratamento-para-variola-de-macaco/#:~:text=Os%20efeitos%20secund%C3%A1rios%20mais%20frequentes,foi%20autorizado%20em%20circunst%C3%A2ncias%20excecionais

Petersen, B. W., Kabamba, J., McCollum, A. M., Lushima, R. S., Wemakoy, E. O., Tamfum, J. M., Nguete, B., Hughes, C. M., Monroe, B. P., & Reynolds, M. G., (2022). Vaccinating against monkeypox in the Democratic Republic of the Congo, 10.1016/j.antiviral.2018.11.004

Pinheiro, L. (2022). Monkeypox: Here's What We Know About Vaccination https://g1.globo.com/saude/vacina/noticia/2022/07/25/variola-dos-macacos-veja-o-que-se-sabe-sobre-a-vacinacao.ghtml

Rizk, J. G., Lippi, G., Henry, B. M., Forthal, D. N., & Rizk, Y. (2022). Prevention and Treatment of Monkeypox, 10.1007/s40265-022-01742-y

Rocha, L. (2022). Como funciona o antiviral tecovirimat contra varíola dos macacos, que deve chegar ao Brasil. https://www.cnnbrasil.com.br/saude/como-funciona-o-antiviral-tecovirimat-contra-variola-dos-macacos-que-deve-chegar-ao-brasil/

Rocha, L. (2022). Entenda quais são e como funcionam as vacinas contra a varíola. https://www.cnnbrasil.com.br/saude/entenda-quais-sao-e-como-funcionam-as-vacinas-contra-a-variola/

Soheili, M., Nasseri, S., Afraie, M., Khateri S., Moradi Y., Mortazavi, S. M. M., & Gilzad-Kohan, H. (2022). Monkeypox: Virology, Pathophysiology, Clinical Characteristics, Epidemiology, Vaccines, Diagnosis, and Treatments, 10.18433/jpps33138.

Stephens, P. R. S., Oliveira, B. S. C., Ribeiro, F. C., & Carneiro, L. A. D. (2009). Virologia https://www.arca.fiocruz.br/bitstream/handle/icict/13725/Conceitos%20e%20Metodos%20V4_Virologia.pdf;jsessionid=BAB0B48BE8802C687EABF502E31BB348?sequence=2

The United Nations Children's Fund. (2019). Vaccines, questions and answers - guidelines https://www.unicef.org/brazil/vacinas-perguntas-e-respostas

Downloads

Published

23/12/2022

How to Cite

RÊGO, A. C. B. do .; LIMA, L. A. G. de .; DUARTE, M. G. .; AMARAL, L. de J. S. do .; LYRA, Z. M. S. de A. L. F. de .; GERMANO, D. A. F. .; DANTAS , F. de O. .; SANTIAGO , G. E. P. .; SAMPAIO, G. M. .; SILVA, L. B. . Monkeypox: generalities, transmission method and therapeutic approaches. Research, Society and Development, [S. l.], v. 11, n. 17, p. e136111738463, 2022. DOI: 10.33448/rsd-v11i17.38463. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/38463. Acesso em: 12 nov. 2024.

Issue

Section

Review Article